21,110
Participants
Start Date
November 18, 2021
Primary Completion Date
February 25, 2025
Study Completion Date
March 30, 2026
Brief Provider Training - Bundled Approach
At each clinic randomized to bundled training, providers will be invited to participate in one, in-clinic, group-based training. Each training will last one-hour and providers will receive continuing medical education (CME) credit for participating. Trainings will focus on introducing the HPV vaccine in a bundle of the other two adolescent vaccines (Tdap and MenACWY).
Brief Provider Training - Benefits Approach
At each clinic randomized to benefits training, providers will be invited to participate in one, in-clinic, group-based training . Each training will last one-hour and providers will receive continuing medical education (CME) credit for participating. Trainings will focus on providers presenting the HPV vaccine as safe, best if received at 11- to 12-years of age, and prevents cancer.
Parent Interactive Text Message - Bundled Approach
Text messages sent to parents will focus on receiving all three adolescent vaccines.
Parent Interactive Text Message - Benefits Approach
Text message will state that the HPV vaccine prevents cancer, is safe and effective, and is recommended for 11- to 12-year-olds.
University of Florida, Gainesville
National Cancer Institute (NCI)
NIH
University of Florida
OTHER